
Publication
M&A in the asset management and fund sector: Key themes for 2025
UK and European asset managers have been facing considerable headwinds over the past few years.
United Kingdom | Publication | September 2022
The CMG scheme had experienced problems following historical mistakes made in the execution of rule amendments relating to the equalisation of normal retirement date for all members and a reduction in the accrual rate.
The scheme rules included the following provision:
Members had been paid lump sums in compensation for underpayments but the employer claimed that the above rule closed off this avenue after six years. The Trustee argued that the rule was merely intended to free up orphaned benefits and identifying missing beneficiaries. The Trustee’s claim was that identifiable members’ benefits were not extinguished, and shortfalls of historic benefits should still be paid.
The court also decided that where trustees seek to recover overpaid benefits by reducing members’ future benefit payments, a county court order is required and a direction from the Pensions Ombudsman will not suffice.
The Lloyds judgment discounted any possibility of a statutory limitation applying to payment of arrears of GMP equalisation benefits but after this judgment it is possible that certain scheme rules may mean limitation applies, depending on the particular way the relevant provisions are expressed.
Publication
UK and European asset managers have been facing considerable headwinds over the past few years.
Publication
Our webinar series will help keep you up-to-date with the major issues and significant developments likely to affect in-house legal teams.
Publication
L’Union Européenne l’avait annoncé , le législateur français l’a fait : le 20 février 2025, l'Assemblée Nationale a adopté définitivement la proposition de loi restreignant la fabrication et la vente de produits contenant des PFAS2, que l’on surnomme les « polluants éternels ».
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025